News & InsightsNewsletterLegislation Hub

Foresight

Foresight
AboutContactBook DemoLog in
Start free trial
Foresight logo
All News & Insights

MSC Endorses Hyalella Azteca Test for Bioaccumulation Studies under REACH

REACH
22
October 2024
•
300
Dr Steven Brennan
The Member State Committee unanimously approves the Hyalella Azteca (HYBIT) test as the new standard for bioaccumulation studies under REACH.
Hyalella Azteca amphipod
AI-Powered Assistant

AI Generated

Ask a question and get instant answers, tailored to your industry and products.

Summarise this article

AI Assistant

Want AI-powered insights like this, but tailored to your products?

Instant analysis of chemical regulations

Alerts matched to your product portfolio

Powerful workflows to streamline your work

Join 2,500+ compliance professionals already using Foresight’s insights to stay ahead of regulation.

Start free trial

Free for 28 days. No credit card needed.

We'll be in touch when the Assistant is ready.
Oops! Something went wrong while submitting the form.
Mountains

During its 87th meeting in October 2024, the Member State Committee (MSC) unanimously approved the adoption of the Hyalella Azteca bioconcentration test (HYBIT) as the standard method for bioaccumulation studies under the REACH regulation. This alternative to the traditional fish-based bioaccumulation test marks a significant shift towards reducing vertebrate testing, fulfilling REACH's aim to use animal testing as a last resort.

The decision supports HYBIT as a valid study method under OECD Test Guideline 321, replacing the Bioaccumulation in Fish study (OECD TG 305) for substances where aqueous exposure is feasible. In cases where aqueous exposure is not possible, the fish study will still be used. The test offers a more ethical and scientifically robust approach, reducing the reliance on vertebrate organisms in line with EU policies promoting animal welfare.

Why the Shift to HYBIT?

The MSC's decision stems from increasing recognition that the Hyalella Azteca test is both scientifically sound and legally justified for a range of substances evaluated under REACH. The test is considered an internationally recognised method within Article 13(3) of the REACH regulation. While relatively new, HYBIT's inclusion marks an important step in applying alternative testing methodologies that align with ethical standards.

Stakeholders voiced concerns over HYBIT’s applicability, particularly for inorganic substances. It was clarified that the OECD has not yet validated HYBIT for these cases, but it remains a viable option for organic substances requiring aqueous exposure testing.

Wider Implications for Regulatory Testing

The approval of HYBIT is part of a broader strategy under REACH to refine substance evaluation processes. By adopting this test, MSC aims to improve the accuracy and relevance of bioaccumulation studies while reducing unnecessary harm to vertebrates. This decision will apply to future dossier evaluations and, where appropriate, in substance evaluation cases.

Read the source story

Read this article now for free!

You have read 3 articles.
Create a free account
or
Log in
to finish reading this article now.

Subscribe to our weekly digest

Sign up to receive our newsletter every Tuesday and get access to all of our content.

By creating an account, you agree to the Terms of Service and Privacy Policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
This is some text inside of a div block.

Trusted by professionals at

Dupont
ECHA - European Chemicals Agency
Energizer
Chemours
This is some text inside of a div block.

Get Foresight Today

Stay compliant, reduce risk, and protect your business with our AI-powered chemical policy monitoring—tailored just for you.

Global monitoring of 1,200+ sources
Expert-reviewed, trusted regulatory alerts
Instant risk identification for 350k+ substances

Ready to supercharge your policy monitoring workflow?

We’ll be in touch soon with more details and support to help you get started.
Oops! Something went wrong while submitting the form.
Share with a friend
Copy link

Related Articles

Plane in skyREACH Annex XVII Update Adds New CMR Restrictions with Aviation Fuel Derogation

August 15, 2025

HSE logoUK REACH 2025/26 Work Programme Sets Regulatory Priorities for Chemical Industry Compliance

August 5, 2025

People in a meetingEU Proposes Major Overhaul of REACH Fees with New SME Verification Rules

August 5, 2025

Foresight regulatory experts
Streamline your chemical compliance
Easy-to-use product compliance management for small and mid-sized manufacturers — mitigate risk and protect market access.
Get started
Subscribe to Foresight's newsletter
Stay ahead with the latest news & insights
Join 1,000s of compliance professionals getting the latest insights right to their inbox for free, every Tuesday.
100% free. No spam. Unsubscribe any time.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Stay ahead with the latest news & insights
Subscribe to our free weekly newsletter covering news, events, and expert insights.

Related articles

Plane in sky

REACH Annex XVII Update Adds New CMR Restrictions with Aviation Fuel Derogation

REACH Annex XVII update adds new CMR substance restrictions with a cumene exemption for aviation fuels. Industry must comply by 1 September 2025.

15

Aug 2025

REACH
HSE logo

UK REACH 2025/26 Work Programme Sets Regulatory Priorities for Chemical Industry Compliance

The UK REACH 2025/26 Work Programme outlines key chemical compliance priorities, including PFAS restrictions and SVHC reviews.

5

Aug 2025

REACH
People in a meeting

EU Proposes Major Overhaul of REACH Fees with New SME Verification Rules

The EU proposes inflation-linked REACH fee increases and a new SME verification model. Affects all chemical manufacturers and importers.

5

Aug 2025

REACH
Foresight
Providing critical insights, analysis, and guidance to help businesses anticipate changes, make informed decisions, and stay ahead.
News & Insights
Newsletter
Legislation Hub
Contact
About
© 2025 Foresight. All rights reserved.
SitemapTerms of servicePrivacy policyCookie policy